The sleep apnea market can be attributed to factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, considerable venture capital funding and the increasing number of companies venturing in to sleep apnea and oral appliances market.
An increasing pool of undiagnosed sleep apnea patients, the improving reimbursement scenario for these devices, and the growth in usage of oral appliances are some of the key factors which are expected to fuel market growth during the forecast period.
By end user, sleep laboratories and hospitals accounted for the largest contributor of sleep apnea devices market.
The momento of devices used in sleep labs and hospitals is limited mainly to diagnostic devices, such as clinical PSG devices, actigraphy systems, and tabletop pulse oximeters. There is a growth in the number of sleep labs and sleep tests performed using a clinical polysomnography device globally, as these tests are being considered the standard diagnostic test for sleep apnea for a long period of time.
North America accounted for a significant share in the sleep apnea devices market in 2018 while the asia pacific region is expected to register in the highest growth during the forecast period.
Factors such as rising prevalence of sleep apnea in the region, increasing initiatives awareness taken by the government and organizations, adequate funding and growing usage of oral appliances in the region is driving the growth of North American sleep apnea disorders.
Comments
Post a Comment